Daniel J. Moore

Daniel J. Moore is a Clinical Associate Professor in the Division of Hematology and Oncology at the University of Washington School of Medicine and a practicing physician at Fred Hutch Cancer Center at EvergreenHealth in Kirkland, WA. He specializes in medical oncology with clinical expertise in lung cancer, breast cancer, hematologic malignancies, gastrointestinal cancers, genitourinary cancers, prostate cancer, and head and neck cancers.

His educational background includes:

• M.D. from University of Texas Southwestern Medical School
• M.S. from University of Texas Southwestern
• Residency in Internal Medicine at University of Texas Southwestern Medical Center
• Fellowship in Hematology-Oncology at Georgetown University
• Fellowship in Developmental Therapeutics at Georgetown University

He maintains board certification in Internal Medicine, Medical Oncology, and Hematology through the American Board of Internal Medicine.

Dr. Moore's research centers on developing novel cancer therapies through late-phase clinical trials, with particular emphasis on immunotherapy applications and innovative early-diagnosis technologies. He actively investigates cancer mechanisms and persistence pathways to improve treatment efficacy. His clinical trial work provides patients access to emerging FDA-reviewed therapies while advancing next-generation cancer care standards.

At Fred Hutch, he operates within a multidisciplinary care framework that integrates physicians, patient care coordinators, nurses, dietitians, social workers, and psychiatrists to deliver comprehensive cancer treatment. Dr. Moore emphasizes personalized patient partnerships, stating: 'I partner with patients by first getting to know them as individuals so we can work together to understand their prognosis and develop the best treatment plan.'